Drug class in one race
Dihydroorotate dehydrogenase (DHODH) drugs for Multiple Sclerosis
2 tracked Dihydroorotate dehydrogenase (DHODH) drugs in the Multiple Sclerosis race. The class explanation lives on the Dihydroorotate dehydrogenase (DHODH) page; the full indication pipeline across every mechanism is on the Multiple Sclerosis page.
1 approved / phase 41 Phase 3
Head-to-head evidence: teriflunomide HMR1726 vs vidofludimus calcium